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With positive outcomes from medical treatments,
monoclonal antibodies (mAbs) are the best-selling biolo-
gics in the pharmaceutical market to date. The medical
value and safety of these molecules have been some-
times reported to be impacted by the carbohydrate
structures that are attached to the N-linked glycosyla-
tion site on the constant region of the mAb, such as
rituximab in which the glycan pattern on its Fc-region
determines the function of rituximab in eliciting
immune response against diseases such as leukemias
and autoimmune disorders that are characterised by
abnormal production of dysfunctional B cells [1]. It has
also been reported that different bioprocess conditions
during recombinant mAb production directly impact
glycan compositions [2,3], although the mechanism
behind this change is not fully understood. This lack of
understanding limits process design and optimisation
efforts. Herein, we examine the effect of mild hypother-
mic conditions. Mild hypothermia during cell culture (e.
g. temperature shift from 36.5°C to 32°C) is commonly
employed to increase the specific recombinant product
productivity (qP) [4,5]. Cells are commonly cultured at
physiological temperature during the start of the pro-
duction stage bioreactor step until desired viable cell
density is obtained; the temperature is then lowered to
mild hypothermic levels (ranges from 28°C to 34°C),
where the lower rates of cell growth are typically com-
pensated for by an the increase in qP. In this study, we
investigate experimentally the effect of mild hypother-
mia (32°C) on mAb N-linked glycosylation, using flux
balance analysis and mathematical modelling to identify
resulting differences in cell metabolism. A mathematical
model that mechanistically and quantitatively has been
constructed to describe four different elements: 1. CHO
cell behaviour and metabolism; 2. mAb synthesis; 3.
Nucleotide sugar donor (NSD) metabolism; and 4. mAb
Fc N-linked glycosylation profiles, before and after the
induction of mild hypothermia. We believe that this is
the first quantitative model that relates mild hypother-
mia to the four elements mentioned above. As the
model aids understanding of the way bioprocess condi-
tions affect product quality, it also provides a platform
for bioprocess design, control and optimisation in indus-
try and helps the implementation of the Quality by
Design principles.
Experimental Approach
Firstly CHO culture performance was measured with
respect to the following: 1. cell growth, nutrient and
metabolite concentrations; 2. mAb production at tran-
scriptional, translational and secretion levels through
quantitative real-time PCR, western blotting and affinity
chromatography; 3. N-linked glycan profiles of the pro-
duct via a LabChip method, as well as 4. mRNA and
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protein expressions of N-linked glycan related enzymes,
in all bioprocess conditions investigated - physiological
and mild hypothermic conditions. To better understand
CHO cell metabolism in all conditions, intracellular car-
bon fluxes were estimated using flux balance analysis [6]
that was constrained with our experimental exometabo-
lite data. Next we related the effect of each process con-
dition with mAb glycosylation with the help of a
modular mathematical model that was adapted from
previous models [7-9]. This describes CHO cell growth,
nutrient metabolism, NSD metabolism, mAb synthesis
and Golgi N-linked glycosylation.
Results and Discussion
CHO cells cultured in mild hypothermic conditions exhib-
ited prolonged cell viability, lower rates of nutrient and
NSD metabolism, as well as a 20% increase in the specific
mAb productivity (qmab). In addition, glycan profiling
showed limitation in terminal galactosylation on the mAb
Fc region at 32°C. Flux balance analysis was used to iden-
tify factors that contributed to changes observed in mAb
Fc-glycosylation under mild hypothermia. The results
demonstrated reduced carbon fluxes towards nucleotide,
NSD and lipid synthesis at 32°C [10]. The modular mathe-
matical model represented the time-course data well, as
Figure 1 Model framework and model simulations of CHO cells cultured in mild hypothermic conditions.
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well as reproducing the N-linked glycosylation profile of
mAb produced under mild hypothermia. Through para-
meter estimation, the model suggested that higher qmAb
observed is accompanied by increased transcription, trans-
lation and transport rates of mAb molecules. Importantly,
estimation results suggested that the rates of NSD produc-
tion and galactosyltransferase (GalT) expression were
reduced at 32°C. This was then confirmed by the experi-
mental measurements of UDP-Gal concentration and
GalT expression levels (Figure 1), thus closing the loop
between experimental and computational systems.
Conclusions
Results from both experimental and computational stu-
dies show that reduced NSD production and lower
expression of N-linked glycosyltransferases are the main
causes of glycan differences in cultures grown under
mild hypothermia. As a result, feeding of nucleosides
and other carbon sources, together with manipulation of
the expression of glycosyltransferase can be employed to
improve mAb glycosylation. In this way, quality can be
built into products and processes to satisfy following the
Quality by Design paradigm.
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